01:32:35
Online course on patient and public involvement (PPI) for applicants of the IICT call 2024
01:26:55
Online course on patient and public involvement (PPI) for applicants of the IICT call 2023
01:53
Cos’è il Coinvolgimento dei Pazienti e del Pubblico (PPI)?
02:02
Qu'est-ce que l’Implication des patient•e•s et du public (l’IPP)?
01:54
What is Patient and Public Involvement (PPI)?
01:57
Was ist Patient and Public Involvement (PPI)?
25:48
Michael Bronstein: HyperFoods: Machine-Intelligent Design of Disease-Beating Foods
21:25
Claudio L. A. Bassetti: SPHYNCS Swiss Primary Hypersomnolence and Narcolepsy Cohort Study
34:43
P. Cippà & D. Malpetti: K-CLIER: framework to exploit single-cell RNAseq in clinical nephrology
19:50
Alessandro Blasimme: Where do we need regulations, and what is already in place or underway?
18:37
Steve Bourke: Patient positive or negative? The developments in artificial intelligence.
07:48
A. Alencar: A Funder's perspective on opportunities & risks of Data Science in Clinical Research
13:54
Dalith Steiger: AI: Industry & Start-up
16:32
Daniel Delfosse: Opportunities and risks of data science and AI
01:28:47
PPI in a Nutshell: Online course on patient and public involvement (PPI), 6 May 2022
01:44:00
PPI in a Nutshell: Online course on patient and public involvement (PPI), 12 April 2022
06:46
Managing the risks of clinical research projects with the SCTO's Risk Assessment Form
17:22
Tanja Colin: CTR and CTIS: Introduction and overview, including the situation in Switzerland
33:57
Andrea Seidel-Glätzer: CTIS submissions: What needs to be considered from an academic point of view
30:27
Fergus Sweeney, EMA: ICH E6 and E8 renovations: Major changes and impact
36:07
Henri Bounameaux, SAMW: What can we expect from the White Paper: Clinical Research
21:01
Annabelle South: Better knowledge transfer in clinical research
12:31
Yvonne Feri: Gesundheitsinformationen für Patientinnen und Patienten: politische Forderung
17:04
Prof Silvia Stringhini: COVID19 communication – recent experiences
05:45
David Haerry: Communicating clinical research results – a patient’s view
06:51
Felix Steiner, ZHAW: Eine linguistische Perspektive für bessere Verständlichkeit
26:58
MD-PhD Ingrid Klingmann: Lay Summaries – what you need to know
21:34
Prof DK Theo Raynor: Communicating clinical trial results – what to watch out for
07:08
Wie ist es, als Patient an einer klinischen Studie teilzunehmen?
07:06
Interview Cordula Landgraf, Communications and Stakeholder Engagement Director
05:06
Clinical research related to COVID-19 | The CORON-ACT study
X
About
The Swiss Clinical Trial Organisation (SCTO) is a research infrastructure of national importance and an academic reference institution for high-quality, patient-oriented clinical research in Switzerland (www.scto.ch).
The seven Clinical Trial Units (CTUs) of the SCTO CTU Network provide all the services and support needed to plan, conduct, and analyse high-quality clinical research projects. Each CTU coordinates one of the eight SCTO Platforms focusing on one key area of clinical research. The SCTO Platforms’ experts provide practical solutions (tools and resources) nationwide for researchers involved in academic clinical research (www.sctoplatforms.ch).
Tags